Research Roundup
The most important preeclampsia research studies, explained for you. A team of diverse researchers scour the peer-reviewed research journals to highlight the most important, cutting edge studies. We try to cover basic, molecular, clinical and population sciences, and a wide range of topics such as new findings in preeclampsia diagnoses, treatment, prevention, long-term effects, risk factors and etiology of preeclampsia.
Based on limited data, pravastatin use during pregnancy does not appear to have any long-term adverse effects on children. his information will be useful for gaining approval for larger studies to see if pravastatin is actually useful in preventing...
In this paper, researchers describe how they developed an ionized lipid nanoparticle that is taken into mouse placental cells to increase VEGF.
Identifying the healthful behaviors that lower the risk for a hypertensive disorder of pregnancy can help develop recommendations and prevention programs to support lowering pregnant women’s risk for developing a hypertensive disorder of pregnancy.
Genetic research over the past 10 years has shown a difference in gene expression in single-cells from placentas of pregnancies with preeclampsia compared to normotensive placentas.
Researchers asked if microRNAs that are linked to cardiovascular disease in non-pregnant people could help predict HELLP syndrome.
This study suggests that women of different BMI classes might have distinct risk profiles for preeclampsia.
Research is being done to make a medicine that can cure preeclampsia a reality. In this article, researchers asked: what are the candidate medicines being studied currently to prevent or treatment preeclampsia?
This is another study on that journey that shows sFlt1 and PlGF are important proteins in pregnant women’s blood that can tell us about preeclampsia risk.
For this study, researchers asked: what are the barriers to eating a heart healthy diet for women with high blood pressure or a hypertensive disorder of pregnancy?
Two articles were published this quarter that both provide updated statistics about trends in preeclampsia and hypertensive disorders of pregnancy in the United States.
In this study, HMOX1 gene variants were different depending on ancestry, and these genetic changes could be contributing to the racial disparity in hypertensive disorders of pregnancy.
These results highlight two new biomarkers with a possibility of being able to predict timing of onset and subtypes of preeclampsia well before preeclampsia is diagnosed.